Specific T cell deletion by transfected human monocytes expressing Fas ligand and antigen

被引:2
作者
Cancedda, C
Suciu-Foca, N
Cortesini, R
Harris, PE
机构
[1] Columbia Univ Coll Phys & Surg, Div Immunogenet, Dept Pathol, New York, NY 10032 USA
[2] Univ Rome La Sapienza, Rome, Italy
关键词
Fas ligand; AICD; APC; DNA vaccination; tolerance;
D O I
10.1016/S0198-8859(00)00117-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The aim of our experiments was to determine whether deletion of antigen specific T helper cells could be accomplished by delivering the antigenic peptide to antigen presenting cells. Tetanus toxin peptide residues 830-843 was chosen for these experiments. Two mammalian expression vectors carrying the genes for human Fas ligand and a chimeric invariant chain-tetanus toxin peptide construct were designed. The T cell proliferative response to tetanus toroid was inhibited when the antigen was Presented by autologus monocytes transfected with Fas ligand. T cell mixture experiments using two syngeneic T cell lines specific either for tetanus toroid or for pertussis toxin demonstrated that the killing effect elicited by the antigen pulsed/Fas ligand-transfected antigen presenting cells was antigen specific. Finally, we demonstrated that transient expression of antigen delivered by plasmid DNA can substitute for soluble antigen in the induction of antigen-specific T cell responses. Antigen presenting cells transfected with thr vector carrying Fas ligand and the vector carrying the chimeric invariant chain-peptide antigen gene were shown to inhibit antigen specific T cell reactivity. This strategy may be useful for the induction of apoptosis in allopeptide reactive T cells driving chronic rejection. (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:575 / 584
页数:10
相关论文
共 24 条
[1]
FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[2]
DEMOTZ S, 1989, J IMMUNOL, V142, P394
[3]
ASSEMBLY AND INTRACELLULAR-TRANSPORT OF HLA-DM AND CORRECTION OF THE CLASS-II ANTIGEN-PROCESSING DEFECT IN T2 CELLS [J].
DENZIN, LK ;
ROBBINS, NF ;
CARBOYNEWCOMB, C ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (07) :595-606
[4]
EISCHEN A, 1992, NOUV REV FR HEMATOL, V34, P421
[5]
Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages [J].
Erbacher, P ;
Bousser, MT ;
Raimond, J ;
Monsigny, M ;
Midoux, P ;
Roche, AC .
HUMAN GENE THERAPY, 1996, 7 (06) :721-729
[6]
The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells [J].
Fujii, S ;
Senju, S ;
Chen, YZ ;
Ando, M ;
Matsushita, S ;
Nishimura, Y .
HUMAN IMMUNOLOGY, 1998, 59 (10) :607-614
[7]
FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[8]
Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis [J].
Johnson, N ;
Ng, TTC ;
Parkin, JM .
LEUKEMIA RESEARCH, 1997, 21 (10) :961-972
[9]
Indirect recognition of donor HLA-DR peptides in organ allograft rejection [J].
Liu, ZR ;
Colovai, AI ;
Tugulea, S ;
Reed, EF ;
Fisher, PE ;
Mancini, D ;
Rose, EA ;
Cortesini, R ;
Michler, RE ;
SuciuFoca, N .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) :1150-1157
[10]
Lu LN, 1997, J IMMUNOL, V158, P5676